Skip to main content
BNC Korea Co, Ltd logo

BNC Korea Co, Ltd — Investor Relations & Filings

Ticker · 256840 ISIN · KR7256840000 KO Manufacturing
Open in API
Filings indexed 283 across all filing types
Latest filing 2020-12-18 Regulatory Filings
Country KR South Korea
Listing KO 256840

About BNC Korea Co, Ltd

http://www.bnckorea.co.kr

BNC Korea Co., Ltd. is a biomedical company established in 2007 that engages in the research, development, production, and sale of medical devices, pharmaceuticals, and biologicals. The company specializes in products derived from biomaterials, with a particular focus on hyaluronic acid. Its core product portfolio includes hyaluronic acid-based dermal fillers and botulinum toxin injectables for the medical aesthetics market. BNC Korea operates a GMP-certified facility for manufacturing cutting-edge drug substances and specialty medicines, aiming to develop strategic application products for next-generation bio markets.

Recent filings

Filing Released Lang Actions
수시공시의무관련사항(공정공시)(비에녹스(BIENOX, 보툴리눔톡신) 공급계약 체결의 건)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure (Fair Disclosure/Gong-jeong-gong-si) from a Korean company, Korea BNC, regarding a supply contract for its products (BIENOX and HA Dermal Filler) in Vietnam. Since this is a specific regulatory announcement of a material business event (a supply contract) that does not fit into categories like M&A, dividends, or financial reports, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for miscellaneous regulatory disclosures.
2020-12-18 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the suspension of share registration (closing of the shareholder register) for the purpose of determining shareholders for an upcoming Annual General Meeting. It does not contain the full report or presentation materials, but rather serves as a formal regulatory announcement of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2020-12-15 Korean
기타경영사항(자율공시)(연령성황반변성 의약물질 공동개발 계약체결)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) from a Korean company regarding a joint development agreement for a pharmaceutical substance. It details the contract terms, financial obligations, and partnership structure with AMD Therapeutics LLC. Since this is a specific corporate announcement regarding a business development/partnership agreement that does not fit into the other specialized categories like M&A or financial reporting, it is classified as a general regulatory filing.
2020-12-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (including specific transactions by special related parties), and the purpose of holding for a major shareholder. This corresponds to the 'Major Shareholding Notification' category.
2020-12-11 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the 3rd quarter of 2020, covering the period from January 1, 2020, to September 30, 2020. It contains detailed company information, business descriptions, capital changes, and financial data, which is characteristic of an interim/quarterly report. It is not a mere announcement or certification, but the full report itself. 9M 2020
2020-11-16 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) from a Korean company, which provides a summary of quarterly financial performance (revenue, operating profit, net income) compared to previous periods. This type of filing is a standard initial announcement of financial results, which fits the definition of an Earnings Release (ER). Q3 2020
2020-11-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.